Curevo Vaccine Employee Directory

Biotechnology ResearchWashington, United States11-50 Employees

Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster, commonly known as shingles. Our goal with a new herpes zoster vaccine is to improve the patient experience and, ultimately, overall vaccination rates, by developing amezosvatein as a vaccine with non-inferior efficacy combined with clinically-meaningful improvements in reactogenicity when compared to Shingrix.

Find Curevo Vaccine employees' phone numbers or email addresses

Curevo Vaccine Global Highlights

Location
Employees

North America
46

Minus sign iconPlus sign icon
  • United States Of America
    46

Europe
2

Minus sign iconPlus sign icon
  • Sweden
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1

Asia
1

Minus sign iconPlus sign icon
  • India
    1

Curevo Vaccine's Leadership

  • Stylized image of a person
    G. D. L. R.
    Chief Medical Officer
    Phone icon
  • Stylized image of a person
    C. L.
    Chief Regulatory Officer
    Phone icon
  • Stylized image of a person
    H. L.
    Director Of Fp&a
    Phone icon
  • Stylized image of a person
    H. M. A. M.
    Director, Translational Research & Development
    Phone icon
  • Stylized image of a person
    J. O. T.
    Director, Clinical Quality
    Phone icon
  • Stylized image of a person
    F. H.
    Controller
    Phone icon
  • Stylized image of a person
    M. C.
    Development Director, Clinical Operations
    Phone icon
  • Stylized image of a person
    M. S.
    Senior Program Manager
    Phone icon

Curevo Vaccine Employee Metrics

100%
50%
0%
2026
2025
  • Program & Project Management
  • Administrative
  • Biotechnology
  • Legal
  • Accounting
  • Other
  • Business
  • Entrepreneurship

Contact profiles from Curevo Vaccine

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    M. B.
    Member Board Of Directors At Curevo
    Phone icon
    United StatesVirginia
    Dec 11, 2025
  • Stylized image of a person
    J. B.
    General Counsel
    Phone icon
    Oct 18, 2024

Frequently Asked Questions

What is Curevo Vaccine known for?

Minus sign iconPlus sign icon
Curevo Vaccine was founded in 2017 operates in the Biotechnology Research industry. The company's main headquarters is located in 21540 30th Drive Southeast Suite 260 Bothell, Washington 98021 United States. Explore Curevo Vaccine's company overview page for more information.

What is Curevo Vaccine's most common email format?

Minus sign iconPlus sign icon
Curevo Vaccine employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Curevo Vaccine email formats with LeadIQ.

How many employees does Curevo Vaccine have currently?

Minus sign iconPlus sign icon
Curevo Vaccine has approximately 45 employees as of February 2026. These team members are located across 3 continents, including North AmericaEuropeAsia.

Who are Curevo Vaccine's key employees and leadership?

Minus sign iconPlus sign icon

As of February 2026, Curevo Vaccine's key employees include:

  • Chief Medical Officer: G. D. L. R.
  • Chief Regulatory Officer: C. L.
  • Director Of Fp&a: H. L.
  • Director, Translational Research & Development: H. M. A. M.
  • Director, Clinical Quality: J. O. T.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.